Clopidogrel Inhibition of Stent, Graft, and Vascular Thrombogenesis With Antithrombotic Enhancement by Aspirin in Nonhuman Primates
- 1 December 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (22) , 2461-2469
- https://doi.org/10.1161/01.cir.98.22.2461
Abstract
Background—A recent study showed that clopidogrel reduces thrombo-occlusive complications in patients with symptomatic atherosclerosis more effectively than aspirin. Methods and Results—The effects...Keywords
This publication has 27 references indexed in Scilit:
- ClopidogrelDrugs, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Two-pronged antiplatelet therapy with aspirin and ticlopidine without systemic anticoagulationCoronary Artery Disease, 1995
- Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre StudyJournal of Internal Medicine, 1990
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKEThe Lancet, 1989
- Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.Journal of Clinical Investigation, 1988
- The therapeutic challenge of plaque rupture: Value of biochemical markersJournal of the American College of Cardiology, 1987
- Experimental Arterial Thromboembolism in BaboonsJournal of Clinical Investigation, 1979
- The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.Journal of Clinical Investigation, 1975